Acceleron Pharma Inc.
🏢 View company profile →172Patents
162Active
172Granted
57Portfolio score
Filing activity: Mar 2, 2005 → Feb 27, 2023 · 31 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7709605B2 | ActRII receptor polypeptides, methods and compositions | Chemistry; Metallurgy | 112 | Active |
| US7842663B2 | Variants derived from ActRIIB and uses therefor | Chemistry; Metallurgy | 103 | Active |
| US7612041B2 | Isolated activin-binding ActRIIa polypeptide comprising the SEQ ID NO: 7 and uses for promoting bone growth | Chemistry; Metallurgy | 90 | Active |
| US8216997B2 | Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators | Chemistry; Metallurgy | 89 | Active |
| US8058229B2 | Method of increasing red blood cell levels or treating anemia in a patient | Chemistry; Metallurgy | 86 | Active |
| US8343933B2 | Variants derived from ActRIIB and uses therefor | Chemistry; Metallurgy | 85 | Active |
| US7988973B2 | Activin-ActRII antagonists and uses for increasing red blood cell levels | Physics | 84 | Active |
| US8178488B2 | Methods for increasing thermogenic adipocytes | Chemistry; Metallurgy | 82 | Active |
| US8252900B2 | Actriib-Fc polynucleotides, polypeptides, and compositions | Chemistry; Metallurgy | 79 | Active |
| US8138142B2 | Methods for increasing adiponectin in a patient in need thereof | Chemistry; Metallurgy | 75 | Active |
| US8895016B2 | Antagonists of activin-actriia and uses for increasing red blood cell levels | Chemistry; Metallurgy | 68 | Active |
| US8293881B2 | Isolated nucleic acid encoding a truncated ActRIIB fusion protein | Chemistry; Metallurgy | 66 | Active |
| US8007809B2 | Activin-actrii antagonists and uses for increasing red blood cell levels | Physics | 66 | Active |
| US8703927B2 | Isolated nucleotide sequences encoding GDF traps | Chemistry; Metallurgy | 55 | Active |
| US8067360B2 | Method for promoting bone growth using activin-ActRIIa antagonists | Chemistry; Metallurgy | 55 | Active |
| US8629109B2 | Method for promoting bone growth using activin-actriia antagonists | Chemistry; Metallurgy | 53 | Active |
| US7951771B2 | Activin-ActRIIa antagonists and uses for promoting bone growth | Chemistry; Metallurgy | 52 | Active |
| US8128933B2 | Method of promoting bone growth by an anti-activin B antibody | Chemistry; Metallurgy | 47 | Active |
| US8703694B2 | Methods for increasing thermogenic adipocytes | Chemistry; Metallurgy | 42 | Active |
| US8765663B2 | Methods for increasing adiponectin | Chemistry; Metallurgy | 40 | Active |
| US7960343B2 | Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion | Chemistry; Metallurgy | 39 | Active |
| US8361957B2 | Isolated GDF trap polypeptide | Chemistry; Metallurgy | 37 | Active |
| US9526759B2 | Activin-actriia antagonists and uses for treating or preventing breast cancer | Physics | 34 | Active |
| US9353356B2 | Activin-actriia antagonists for treating a follicle-stimulating horomone-secreting pituitary tumor | Chemistry; Metallurgy | 34 | Active |
| US8367611B2 | Activin-actriia antagonists for inhibiting germ cell maturation | Chemistry; Metallurgy | 33 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.